David Altschul, MD, has become a national expert in the use of these next generation endovascular devices, including the Woven EndoBridge (WEB) system, which allows for blood inflow disruption at the neck of the aneurysm with aneurysmal filling and flow diversion in a single implant. As one of the first in the nation to use the FDA-approved device, Dr. Altschul has extensive experience with one of the largest volumes of cases in the country.  A thought leader in the field, he teaches and trains other physicians on how to use it, speaks at national conferences and publishes research on the subject. 

Over the last decade, treatment of brain aneurysms has moved away from open surgery to endovascular treatment, except for certain shaped aneurysms, known as wide-necked bifurcation aneurysms. These complex aneurysms remained a challenge to treat with catheter-based, minimally invasive techniques as the aneurysmal opening is commonly too wide for the use of conventional coils, until new devices, called endovascular flow disruptors, became available . 

Led by David Altschul, MD, as principal investigator, Montefiore Einstein is participating in numerous clinical trials looking at new and improved devices, such as Contour and Trenza, to treat brain aneurysm and achieve better and safer outcomes for our patients.